HomeVEEV • NYSE
add
Veeva Systems Inc
Previous close
$279.20
Day range
$278.66 - $282.47
Year range
$177.41 - $291.69
Market cap
46.16B USD
Avg Volume
1.44M
P/E ratio
59.92
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | 759.04M | 16.71% |
Operating expense | 351.49M | 11.13% |
Net income | 228.19M | 41.15% |
Net profit margin | 30.06 | 20.92% |
Earnings per share | 1.97 | 31.33% |
EBITDA | 243.55M | 44.40% |
Effective tax rate | 23.64% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.07B | 27.35% |
Total assets | 7.77B | 25.50% |
Total liabilities | 1.55B | 19.70% |
Total equity | 6.21B | — |
Shares outstanding | 163.41M | — |
Price to book | 7.33 | — |
Return on assets | 7.74% | — |
Return on capital | 9.58% | — |
Cash Flow
Net change in cash
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | 228.19M | 41.15% |
Cash from operations | 877.16M | 14.88% |
Cash from investing | -52.11M | 80.87% |
Cash from financing | 20.38M | 432.39% |
Net change in cash | 846.20M | 71.40% |
Free cash flow | 843.22M | 14.14% |
About
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud software, data, and business consulting for the life sciences industry. Its software is used to manage data, track regulatory registrations, and oversee supply chains. The company is a public benefit corporation.
The company has 1,477 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Its primary competitor for its customer relationship management software is Salesforce, which is partnered with IQVIA. Wikipedia
Founded
2007
Headquarters
Website
Employees
7,291
